Predictors of response to infliximab in patients with Crohn's disease
- 1 September 2002
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 123 (3) , 707-713
- https://doi.org/10.1053/gast.2002.35390
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Impatient and outpatient costs of care for inflammatory bowel disease in the year 2000Gastroenterology, 2001
- Treatment of Crohn's disease with infliximab—An initial community practice experienceGastroenterology, 2000
- Pretreatment with 6-mercaptopurine/azathioprine (6MP/AZA) prolongs clinical response time in Crohn's disease (CD) patients with fistulizing disease (FD) treated with infliximab (INF)Gastroenterology, 2000
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Oral contraceptive use and smoking are risk factors for relapse in Crohn's diseaseGastroenterology, 1998
- Effect of cigarette smoking on the course of Grohnʼs diseaseEuropean Journal of Gastroenterology & Hepatology, 1996
- Construction and initial characterization of a mouse-human chimeric anti-TNF antibodyMolecular Immunology, 1993
- Smoking in Crohn's disease: effect on localisation and clinical course.Gut, 1992
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980